Verep, S. Et Al. 2019. The pathological upgrading after radical prostatectomy in low-risk prostate cancer patients who are eligible for active surveillance: How safe is it to depend on bioptic pathology?. The Prostate , vol.79, no.13 , 1523-1529.

Verep, S., Erdem, S., Ozluk, Y., Kilicaslan, I., Sanli, O., & Ozcan, F., (2019). The pathological upgrading after radical prostatectomy in low-risk prostate cancer patients who are eligible for active surveillance: How safe is it to depend on bioptic pathology?. The Prostate , vol.79, no.13, 1523-1529.

Verep, Samed Et Al. "The pathological upgrading after radical prostatectomy in low-risk prostate cancer patients who are eligible for active surveillance: How safe is it to depend on bioptic pathology?," The Prostate , vol.79, no.13, 1523-1529, 2019

Verep, Samed Et Al. "The pathological upgrading after radical prostatectomy in low-risk prostate cancer patients who are eligible for active surveillance: How safe is it to depend on bioptic pathology?." The Prostate , vol.79, no.13, pp.1523-1529, 2019

Verep, S. Et Al. (2019) . "The pathological upgrading after radical prostatectomy in low-risk prostate cancer patients who are eligible for active surveillance: How safe is it to depend on bioptic pathology?." The Prostate , vol.79, no.13, pp.1523-1529.

@article{article, author={Samed Verep Et Al. }, title={The pathological upgrading after radical prostatectomy in low-risk prostate cancer patients who are eligible for active surveillance: How safe is it to depend on bioptic pathology?}, journal={The Prostate}, year=2019, pages={1523-1529} }